All Disease X articles
-
NewsWHO Member States continue negotiations on the Pathogen Access and Benefit Sharing Annex
WHO Member States have advanced negotiations on the Pathogen Access and Benefit Sharing (PABS) annex, while agreeing that continued discussions are needed to finalize a framework that supports a faster, more effective and equitable response to future pandemics.
-
FeaturesAdvancing animal disease outbreak management in support of a One Health approach
Animal health is often overlooked, with global expenditure reaching just a fraction (around 0.4 percent) of total human health spending, yet it is a crucial component of the World Health Organization’s (WHO) One Health approach. The One Health initiative highlights the commonalities between human, animal and environmental health and aims ...
-
NewsEmerging tick-borne virus raises concern
A study shows how a family of tick-borne viruses known as orthonairoviruses can evade immune defenses, offering important insights into emerging infectious disease threats and the potential pandemic risk posed by these viruses.
-
NewsChikungunya fever: Etiology, pathogenesis, and management, with evidence-based application of traditional Chinese medicine
Traditional Chinese medicine (TCM) offers complementary strategies for acute symptoms and chronic polyarthralgia in Chikungunya infection. A review synthesizes current knowledge on etiology, pathogenesis, clinical features, and management.
-
NewsNo entry: Blocking viruses from entering cells
The Volkswagen Foundation funds a project by UdS, HIPS, and HZI to create an innovative platform for developing viral entry inhibitors—specifically targeting respiratory viruses and other viruses that pose a pandemic risk.
-
NewsKorea University College of Medicine Vaccine Innovation Center selected to lead KDCA-funded hantavirus vaccine development project
The Vaccine Innovation Center at Korea University College of Medicine has been selected by the Korea Disease Control and Prevention Agency (KDCA) as the lead institution for a national hantavirus vaccine development project.
-
ArticleCOVID-19 vaccine boosters may help protect against future animal coronaviruses
COVID-19 vaccine boosters not only protect against SARS‑CoV‑2 but may also help protect against some future coronaviruses that risk spreading from animals to humans, researchers have shown.
-
NewsHantavirus in the South Atlantic: A one health and microbiome wake‑up call
The hantavirus pulmonary syndrome outbreak on MV Hondius shows how global travel and environmental change are reshaping how zoonotic viruses emerge. In a new commentary, Professor Lu proposes four initiatives aligned with Microbiome and One Health.
-
OpinionWhy cruise ships remain vulnerable to viral outbreaks - and how new technologies could help
A dream holiday can quickly become a public health challenge when thousands of people share the same dining rooms, elevators and living spaces. Recent viral outbreaks on cruise ships have shown just how vulnerable these floating cities remain to infectious diseases.
-
NewsOropouche virus has already infected more than 5 million people in Brazil, study suggests
The recent Oropouche virus outbreak in 2023 has drawn attention in Brazil and other Latin American countries because of its scale and rapid spread. Researchers estimate that since 1960, the virus has infected approximately 9.4 million people in Latin America and the Caribbean.
-
NewsReservoir of drug-resistant germs IDed in national surveillance collaboration
Researchers who screened more than 2,000 samples across 42 states say there is a rapidly evolving, plasmid-driven epidemic of community-associated multidrug resistant Klebsiella pneumoniae across the United States.
-
NewsJust 10 viral particles can cause H5N1 avian flu infection in cows
Just 10 viral particles of the H5N1 bird flu that caused hundreds of influenza outbreaks in U.S. dairy cattle can cause infection in cows, a new study shows. The research also hints at why the outbreaks have confounded scientists, farmers and livestock handlers hoping to contain and prevent the disease.
-
NewsAs California warms, cases of dengue fever are expected to grow
Historically, dengue fever has been rare in California. But according to new research, a warming climate is making parts of the state more hospitable to the illness — and the mosquitoes that carry it.
-
NewsClimate-driven dengue surge: Predicting future outbreak risk across Costa Rica
Scientists have developed a practical framework for predicting how shifting temperature and precipitation patterns could influence dengue fever outbreaks across Costa Rica.
-
NewsChina’s psittacosis knowledge gap: A scoping review calls for coordinated action
Psittacosis—a bacterial pneumonia transmitted from birds to humans—is experiencing a notable resurgence in China. A new review presents a sobering picture: psittacosis is epidemiologically substantive, clinically serious, and chronically underserved by institutional resources and public health infrastructure.
-
NewsFirst-in-human clinical trial shows promising results for new Lassa fever vaccine
Researchers have reported encouraging results from an early clinical trial that tested a new dual vaccine against Lassa fever and rabies. The study found that the vaccine was safe and induced immune responses against both viruses. There are currently no vaccines against Lassa fever on the market.
-
NewsNew model could help track deadly viruses back to their source
A new predictive model could help scientists more efficiently identify the reservoirs of emerging zoonotic viruses and dangerous pathogens like Ebola that can spill over from animals into humans. It relies on detailed information collected on suspected reservoir species to identify key windows.
-
NewsT cells may be key to stopping measles virus—and its deadly relatives
Scientists have discovered how T cells target paramyxoviruses, a viral family that includes measles virus and Nipah virus. Instead of vaccinating against one virus at a time, the researchers found that activating “cross-reactive” T cells may protect against the wider paramyxovirus family.
-
NewsPan-European One Health Network established to bolster infectious disease response
iiCON: the Infection Innovation Consortium has successfully secured funding from COST to establish a unique pan-European COST Action network with over 70 collaborators from 21 countries and international organisations to harmonise the European response to infectious disease threats.
-
CareersA week in the life of a Parvovirus researcher
Alejandro Fernández Llorente works as a predoctoral researcher at Centro de Biología Molecular Severo Ochoa (CBM-CSIC), a prestigious biomedical research centre located in Madrid, Spain.